CELC vs ABVX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABVX Captures Institutional Edge (2โ1 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abivax SA American Depositary Shares (ABVX) driven by superior Momentum & Technical, Options & Structure while CELC counters with relative strength in Growth & Margin. Fundamentally, CELC trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ABVX at N/M Forward P/E and -6270.4% operating margin (-6.8% YoY). In options structure, CELC sits in BREAKDOWN (30th %ile IV; Dealer Gamma Walls on Pro) against ABVX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CELC | ABVX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.2B | $7.9B | Larger Scale | ABVX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | -6.8% | Higher Growth | CELC |
| Operating Margin (TTM) Profitability | 0.0% | -6270.4% | Higher Margin | CELC |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -1192.9% | -252.3% | Higher ROE | ABVX |
| 52-Week Range Position Momentum | 8% ($54โ$151) | 17% ($70โ$149) | Stronger Trend | ABVX |
| Beta / 30D Volatility Risk Regime | 1.28ฮฒ ยท 60% Vol | 1.38ฮฒ ยท 48% Vol | Lower Realized Risk | ABVX |
| Unified Institutional Score Composite Signal | 39.7 / 100 (SELL) | 55.6 / 100 (HOLD) | Higher Composite | ABVX |